Jinwon Life Sciences Secures $2.3 Billion Plasmid DNA Supply Contract from US Biotech Company
[Asia Economy Reporter Park Junyi] Jinwon Life Science announced on the 8th that it has secured a plasmid DNA supply contract worth 2,278,950,000 KRW from a US biotech company.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Was This Delicious Treat Enjoyed Only by Koreans?"... The K-Dessert Captivating Japan
- "Iran Considers Usage Fees From Surface to Seabed, Eyes $15 Billion Annual Revenue"
- Former Google CEO: "AI Is Unavoidable"... U.S. Graduates Boo
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
The contract amount is 5.53% of the consolidated sales in 2019. The contract will end on March 31, 2022.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
